-transparent.png){kind=logo}
Details are given of response and toxicity after high dose chemotherapy followed by autologous bone marrow infusion. High dose nitrosurea therapy (600-1000 mg/m2 BCNU) was predominantly associated with hematopoietic toxicity but recovery was within 4-5 weeks after BCNU therapy. High dose combination chemotherapy using cytoxan, VP-16-23 and +/- BCNU produced a response rate of approximately 80% (CR + PR + less than PR) of usually short duration in 18 evaluable patients, 17 of whom were previously treated. Hematopoietic recovery was usually complete in 4 weeks. Initial experience with the hematopoietic toxicity experienced after high dose mitomycin and ABMT is also detailed. Future proposals utilizing high dose chemotherapy with ABMT in selected tumors is presented with associated rationale.
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
March 1964,
Annals of the New York Academy of Sciences,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
February 1993,
Bulletin du cancer,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
January 1989,
European journal of haematology. Supplementum,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
December 1986,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
January 1991,
Bone marrow transplantation,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
July 1988,
Transplantation,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
January 1992,
JAMA,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
March 1983,
Gan to kagaku ryoho. Cancer & chemotherapy,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
December 1993,
Journal of the National Cancer Institute,
G Spitzer, and
K A Dicke, and
D S Verma, and
A Zander, and
J Litam, and
A DiStefano, and
V Lanzotti
December 1989,
Onkologie,
